Unusual neuromuscular toxicity after treatment of bone sarcomas with adriamycin, vincristine, and cyclophosphamide.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009468:Neuromuscular Diseases / Q000139:chemically induced*; D012516:Osteosarcoma / Q000188:drug therapy*; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide